“Smart Money” Bets Big on Emerald Health

Billions of dollars worth of business awaits early-market entrants that can pioneer proven medicinal formulas from cannabis.

That’s why a race to riches has just begun among a handful of Canada’s licensed, industrial-scale medical marijuana growers – each of whom wants to capitalize on in-house “intellectual property”or “IP” that can turn cannabis into mainstream medicine.

Any company that can successfully do that will likely be able to cash-out – assuming it’s acquired by “Big Pharma”– with a billion-dollar-plus market capitalization.

Click here to read the entire article

 

Article by: Marc Davis on Stockhouse.

2017-06-02T15:56:47+00:00 February 17th, 2017|Media|